BioCentury
ARTICLE | Company News

Ario Pharma, Xention pulmonary news

December 16, 2013 8:00 AM UTC

Xention spinout Provesica Ltd. changed its name to Ario, shifted its focus to respiratory diseases and raised £1.9 million ($3.1 million) in a series A round. Ario will develop Phase I compound XEN-...